Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transwell Biotech Co., Ltd.
Hsinchu, Taiwantw-bio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Completed Phase I clinical trial for TWB-103 for donor site wounds in Taiwan. Currently conducting Phase I/II clinical trials in Taiwan and Japan for TWB-103 in adults with skin graft donor site wounds.
- Therapeutic areas
- Dermatology
- Modalities
- Cell therapyExtracellular Vesicles (EVs)Exosomes
- Industry
- Biotech
02
Partnerships
Elanix Biotechnologies AG (Switzerland)
Beyond the preview
Go deeper on Transwell Biotech Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transwell Biotech Co., Ltd..